Render Target: SSR
Render Timestamp: 2025-04-02T01:28:04.249Z
Commit: 779953b12a5930618aae6aca7c87fb286faeb1d7
XML generation date: 2025-03-07 13:19:00.653
Product last modified at: 2025-03-10T11:15:12.225Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

ATF7IP (F8C9I) Rabbit mAb #28299

Filter:
  • WB
  • IP
Western Blotting Image 1: ATF7IP (F8C9I) Rabbit mAb
Western blot analysis of extracts from various cell lines using ATF7IP (F8C9I) Rabbit mAb (upper) or α-Actinin (D6F6) XP® Rabbit mAb #6487 (lower). Low expression of ATF7IP protein in HuH-6 cells is consistent with the predicted expression pattern.

To Purchase # 28299

Supporting Data

REACTIVITY H Mk
SENSITIVITY Endogenous
MW (kDa) 190, 220
Source/Isotype Rabbit IgG
Application Key:
  • WB-Western Blotting 
  • IP-Immunoprecipitation 
Species Cross-Reactivity Key:
  • H-Human 
  • Mk-Monkey 
  • Related Products

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunoprecipitation 1:100

Protocol

Specificity / Sensitivity

ATF7IP (F8C9I) Rabbit mAb recognizes endogenous levels of total ATF7IP protein.

Species Reactivity:

Human, Monkey

Source / Purification

Monoclonal antibody is produced by immunizing animals with recombinant protein specific to the amino terminus of human ATF7IP protein.

Background

Activating transcription factor 7-interacting protein (ATF7IP), also known as MCAF1 or AM, is a repressive chromatin factor that binds to SETDB1, enhancing its ability to catalyze histone H3 lysine 9 trimethylation (1-3). ATF7IP has a SUMO binding domain, which interacts with sumoylated MBD1 to recruit the SETDB1/ATF7IP heterodimer to sites of heterochromatin (4). Loss of ATF7IP results in degradation of SETDB1 protein and a global loss of H3K9me3 (5). ATF7IP can localize to PML bodies in a SUMO-dependent manner, causing reduced histone mRNA and protein and cellular senescence (6). ATF7IP has also been implicated in cancer, where it interacts with SP1 to regulate telomerase. It can also contribute to immune cell function by inhibiting the IL-2 and IL-7R genes (7-9).
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our Trademark Information page.